IGC Pharma, Inc. - Director's Dealing 2017

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2017-03-31

Reporting Person: PRINS RICHARD K (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-23	Common stock	G	2000	—	Disposed	387000	Direct
2016-12-30	Common stock	G	2000	—	Disposed	385000	Direct
2017-01-06	Common stock	G	2000	—	Disposed	383000	Direct
2017-01-13	Common stock	G	2000	—	Disposed	381000	Direct
2017-01-23	Common stock	G	2000	—	Disposed	379000	Direct
2017-01-27	Common stock	G	2000	—	Disposed	377000	Direct
2017-02-03	Common stock	G	2000	—	Disposed	375000	Direct
2017-02-10	Common stock	G	2000	—	Disposed	373000	Direct
2017-02-17	Common stock	G	2000	—	Disposed	371000	Direct
2017-02-24	Common stock	G	2000	—	Disposed	369000	Direct
2017-03-03	Common stock	G	2000	—	Disposed	367000	Direct
2017-03-10	Common stock	G	2000	—	Disposed	365000	Direct
2017-03-17	Common stock	G	2000	—	Disposed	363000	Direct
2017-03-27	Common stock	G	2000	—	Disposed	361000	Direct
2017-03-31	Common stock	G	2000	—	Disposed	359000	Direct
2017-04-07	Common stock	G	2000	—	Disposed	357000	Direct
2017-04-14	Common stock	G	2000	—	Disposed	355000	Direct
2017-04-21	Common stock	G	2000	—	Disposed	353000	Direct
2017-04-28	Common stock	G	2000	—	Disposed	351000	Direct
2017-05-05	Common stock	G	2000	—	Disposed	349000	Direct